LeMaitre Vascular (NASDAQ: LMAT) — Perfil da empresa, notícias e dados financeiros
LeMaitre Vascular manufactures medical devices for vascular diseases, specializing in minimally invasive surgical solutions.
LeMaitre Vascular
LeMaitre Vascular (NASDAQ:LMAT) specializes in developing, manufacturing, and marketing medical devices for the treatment of vascular diseases. Its product portfolio includes technologies aimed at improving the effectiveness and efficiency of vascular surgery, with an emphasis on minimally invasive procedures. The company is deeply invested in ongoing research and development projects to advance vascular treatment options, aiming to enhance patient outcomes and streamline surgical practices. With a global operational footprint, LeMaitre Vascular is focused on expanding its market presence and establishing itself as a trusted partner in the vascular health sector by providing innovative solutions that address the evolving needs of healthcare professionals and their patients.
Resumo
Operações
Produtos e/ou serviços de LeMaitre Vascular
- XenoSure Biologic Patches are used in vascular surgery to repair blood vessels, offering an effective solution for tissue regeneration.
- The Over-the-Wire LeMaitre Valvulotome offers precision in in-situ bypass surgeries, enhancing operational success.
- AlboGraft Polyester Vascular Grafts are designed for arterial and aortic grafting, providing durable and reliable alternatives for various vascular surgeries.
- The ProCol Vascular Bioprosthesis assists with hemodialysis access maintenance, significantly improving patient outcomes.
- AnastoClip Vascular Closure System ensures secure closure of vascular sutures, minimizing leakage and promoting faster healing.
- The TAArget Thoracic Stent Graft provides a minimally invasive solution for the treatment of thoracic aortic aneurysms, enhancing patient recovery times.
equipe executiva do LeMaitre Vascular
- George W. LeMaitreChairman & CEO
- David B. RobertsPresident & Director
- Dorian P. LeBlancChief Financial Officer
- Trent G. KamkeSenior Vice President of Operations
- George D. LeMaitreFounder and Chairman of Scientific Advisory Board
- Laurie A. ChurchillChief Legal Officer
- Kimberly L. CieslakVice President of Marketing
- Daniel J. MumfordSenior Director of Human Resources
- Jonathan W. NgauSenior Vice President of Information Technology
- Maik D. HelmersSenior Vice President of Sales ? Central Europe
Histórico de dividendos
Dividendos por ação pagos pela LeMaitre Vascular, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $0.7500 |
| FY2025 | — | — | — | $0.8000 |
| FY2024 | — | — | — | $0.6400 |
| FY2023 | — | — | — | $0.5600 |
| FY2022 | — | — | — | $0.5000 |
Principais indicadores financeiros
Resultados divulgados pela LeMaitre Vascular, em USD.
- Cap. de mercado
- 1,9 bi
- Receita (TTM)
- 262,4 mi
- P/L
- 29.4
- LPA (diluído, TTM)
- 2.9
- Dividend yield
- 1.1%
- Margem de lucro
- 25.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 249,6 mi | 67,9 mi | 57,7 mi | |
| 219,9 mi | 52,3 mi | 44 mi | |
| 193,5 mi | 36,7 mi | 30,1 mi | |
| 161,7 mi | 26,8 mi | 20,6 mi |